BFA
CHTP

BlackRock Fund Advisors’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

BlackRock Fund Advisors’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,187,418
Closed -$12.1M – 3948
2014
Q1 		$12.1M Buy
2,187,418
+77,787
+4% +$390K ﹤0.01% 2288
2013
Q4 		$9.36M Buy
2,109,631
+207,336
+11% +$701K ﹤0.01% 2436
2013
Q3 		$5.69M Buy
1,902,295
+220,493
+13% +$633K ﹤0.01% 2716
2013
Q2 		$3.87M Buy
+1,681,802
New +$3.4M ﹤0.01% 2859

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BlackRock Fund Advisors's CHTP Position: Q2 2014 in Review

BlackRock Fund Advisors sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 2,187,418 shares — an estimated $12.1M sold.

BlackRock Fund Advisors first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $12.1M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • BlackRock Fund Advisors reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • BlackRock Fund Advisors sold 2,187,418 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $12.1M.
  • BlackRock Fund Advisors first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • BlackRock Fund Advisors's CHELSEA THERAPEUTICS INT'L LTD position peaked at $12.1M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on BlackRock Fund Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.